Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.
As Commercial Lead – Netherlands, drive the overall commercial success of our portfolio in the Dutch market, shape the go-to-market strategy, accelerate revenue growth, and ensure sustainable patient access.
Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.
Stryker